Overview and Goals
Organizational Structure
Contact Us
Services to Investigators
The Process
Eligibility
Services and Pricing
Array Platforms
Educational Resources
Services to the Public
Data And Analysis Policies
Publications
Microarray Resources
Navigate Repository
Register
Username:
Password:
Forgot Password?
Home
View Project Russell-3U24NS043571-01S1-2
Project Summary
Status:
Public
Publications:
1 Published
Project Detail
Data Detail
Platform:
Affymetrix
MIAME Areas
Compliance
Species:
Human
Array Design Detail
true
Organ/Tissue Type:
Experiment Detail
false
Organ Region:
Sample Detail
false
Cell Type:
fibroblast
Hybridization Detail
false
Study Type:
pharmacogenomic
Measurement Detail
false
Disease/Condition:
Active tumor
Replicates:
2
Expected Samples:
6
Available Actions
Investigator Contact Detail
Name
Paul Russell
Street Address:
School of Veterinary Medicine, Unversity of Wisconsin
2015 Linden Drive
City, State/Province:
Madison , WI
Zip/Postal Code:
35706
Country:
United States
Work Phone:
(608) 262-5652
Fax:
E-mail:
russellp@svm.vetmed.wisc.edu
Proposal Detail
Grant:
3U24NS043571-01S1
Status:
Public
Service Type:
Start to Finish Profiling
IRB:
TBA
IRB date:
2003-09-03
Study Relevance:
TGF-beta levels are known to increase in the aqueous humor of eye cells in patients with glaucoma. Increase TGF-beta is assumed to have a biochemical impact on the trabecular meshwork, and an increase in extracellular matrix formation, which may be responsible for decrease outflow facility of the eye. This may increase extracellular pressure, causing glaucoma. TGF-beta 1 may be the cause of abnormal accumulation of extracellular matrices in trabecular meshwork of eyes with primary open angle glaucoma. Transforming growth factor (TGF)-beta2 regulates the expression of proteoglycans in aqueous humor from human glaucomatous eyes.
Hypothesis:
We expect to see a change in expression of the proteoglycans in HTM cells as a response to TGF-beta treatment.
Specific Aim:
To identify gene expression changes as a result of TGF-beta1 and 2 treatment of human trabecular meshwork cells.
Experimental Procedure and Design:
Human Trabecular Meswork cells in the eye were bathed by aqueous humor. TM cells were removed from individuals with the following ages: 16,66,67,73, and 76. Each individual was treated with EtOH (control), TGF-beta1, or TGF-beta2. Total RNA from each individual was pooled for each chip. Technical replicates were created for each treatment type, for a total of 6 chips.
Experimental Factors:
Conditions that are tested in the experiment. At least one is required. Experimental factors are the independent variables in the experiment.
Experimental Factors is empty.
Project Samples
Samples associated with this project.
Action Button Key
View Sample
Name
Description
Bio-Source
Extracts
Ctr TM 2a
Human Trabecular Meshwork
BioSource6
1
Ctr TM 2b
Human Trabecular Meshwork
BioSource7
1
TGF-beta1 TM 1a
Human Trabecular Meshwork
BioSource8
1
TGF-beta1 TM 1b
Human Trabecular Meshwork
BioSource9
1
TGF-beta2 TM 1a
Human Trabecular Meshwork
BioSource10
1
TGFbeta-2 TM 1b
Human Trabecular Meshwork
BioSource11
1
Project Hybridizations
Action Button Key
View Hybridization
Name
Array
Labeled Extract
Hybridization Protocol
HG-U133A_1_hyb
HG-U133A_1
Ctr TM 2a_e1_le1
HG-U133A_2_hyb
HG-U133A_2
Ctr TM 2b_e1_le1
HG-U133A_3_hyb
HG-U133A_3
TGF-beta1 TM 1a_e1_le1
HG-U133A_4_hyb
HG-U133A_4
TGF-beta1 TM 1b_e1_le1
HG-U133A_5_hyb
HG-U133A_5
TGF-beta2 TM 1a_e1_le1
HG-U133A_6_hyb
HG-U133A_6
TGFbeta-2 TM 1b_e1_le1
Project Reference Files
File Name
Size
PHG-CtrTM-2aUA-s2.CEL
11.68 Mb
PHG-CtrTM-2bUA-s2.CEL
11.59 Mb
PHG-TGFbeta1TM-1aUA-s2.CEL
11.57 Mb
PHG-TGFbeta1TM-1bUA-s2.CEL
11.66 Mb
PHG-TGFbeta2TM-1aUA-s2.CEL
11.59 Mb
PHG-TGFbeta2TM-1bUA-s2.CEL
11.54 Mb
Contact Us
Providing microarray resources to investigators since 2002
NIH Neuroscience Microarray Consortium
Version 3.2.13
Site built by